51 results on '"Kuball, J"'
Search Results
2. Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP)
3. Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies
4. P957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY A SECOND AUTO-HCT IS AN EFFECTIVE STRATEGY IN FIRST RELAPSE MULTIPLE MYELOMA: A STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT
5. P1444: IMPACT OF CO-MORBIDITIES ON NON-RELAPSE MORTALITY AND CYTOKINE-RELEASE SYNDROME AFTER CD19 CAR-T CELL THERAPY - A RETROSPECTIVE STUDY FROM THE TCWP OF THE EBMT AND GOCART COALITION
6. P1382: RUXOLITINIB USE IN A REAL WORLD ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE COHORT IN THE NETHERLANDS: A RETROSPECTIVE STUDY
7. Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
8. TEG001 insert integrity from vector producer cells until medicinal product
9. Targeting Acute Leukemia and Cancer by High-Affinity T-Cell-Receptor Transfer
10. Identification of a tumor-specific allo-HLA–restricted γδTCR
11. Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes
12. PF722 SYMPTOMS AND HEALTH-RELATED QUALITY OF LIFE OF PATIENTS ONE YEAR AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
13. Clinical versus histological grading in the assessment of cutaneous graft versus host disease
14. Cardio-oncology: an overview on outpatient management and future developments
15. Jon van Rood (1926–2017)
16. In search of the optimal platform for Post-Allogeneic SCT immunotherapy in relapsed multiple myeloma: a systematic review
17. JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvement
18. OA3-1 Allogeneic stem cell transplantation in HIV-1-infected individuals; the EPISTEM consortium
19. Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio
20. Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma
21. Post-mortem analysis of HIV-1 reservoir after allogeneic transplantation using stem cells
22. Allogeneic stem cell transplantation in HIV-1 infected individuals
23. Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
24. Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells
25. Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCT
26. Treatment of steroid resistant grade II to IV acute GVHD by infusion of mesenchymal stromal cells expanded with platelet lysate - a phase I/II study
27. Translating in vitro prediction of cytotoxic T cell alloreactivity to hematopoietic stem cell transplantation outcome
28. Hunting for clinical translation with innate-like immune cells and their receptors
29. γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia
30. The impact of frequent HLA haplotypes in high linkage disequilibrium on donor search and clinical outcome after unrelated haematopoietic SCT
31. The circulating platelet count is not dictated by the liver, but may be determined in part by the bone marrow: analyses from human liver and stem cell transplantations
32. The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study
33. Influence of Donor Cytomegalovirus (CMV) Status on Severity of Viral Reactivation after Allogeneic Stem Cell Transplantation in CMV-Seropositive Recipients
34. B- Cell Depletion As Therapy For Steroid Refractory Chronic GVHD Is Most Effective For Sclerosis Of The Skin
35. Modulation of the longevity proteins FOXO3a and SIRT1 by chorionic gonadotropin prevents hepatocellular injury during acute liver inflammation
36. The Programmed Death (PD)‐1/PD‐Ligand 1 Pathway Regulates Graft‐Versus‐Host‐Reactive CD8 T Cells After Liver Transplantation
37. Schmerzerfassung bei invasiven diagnostischen Prozeduren
38. MMP–7 vermittelte Immuntoleranz nach adoptivem T-Zelltransfer in vivo
39. Inhibitors of apoptosis confer resistance to tumour suppression by adoptively transplanted cytotoxic T-lymphocytes in vitro and in vivo
40. Die Spaltung von Osteopontin durch MMP–7 verändert die Interaktion zwischen zytotoxischen T-Zellen und HepG2-Zellen
41. Control Of Organ Transplant-Associated Graft-versus-Host Disease By Activated Host Lymphocyte Infusions
42. MMP–7 vermittelte Hemmung der CTL-Tumorzell Interaktion
43. MMP-7-induzierte Apoptoseresistenz durch Spaltung von CD95
44. Generating p53-specific cytotoxic T lymphocytes by recombinant adenoviral vector-based vaccination in mice, but not man
45. T-Zelltherapien in der Onkologie
46. Successful Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients With Bladder Cancer by Intravesical Vector Instillation
47. Gen-Immuntherapie zur Gen-Immuntherapie zur Behandlung von Malignomen Behandlung von Malignomen
48. Gentherapeutischer T-Zell-Rezeptor-Transfer
49. Gentherapie solider Tumore
50. Übersicht laufender Immuntherapiestudien
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.